Search

Search Constraints

You searched for: Author/Creator Taguchi, Jun

Search Results

11. Detailed analysis of failure patterns using deformable image registration in hypopharyngeal cancer patients treated with sequential boost intensity‐modulated radiotherapy. Issue 1 (14th November 2022)

12. Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D‐first study. Issue 9 (September 2015)

13. Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study. Issue 8 (30th August 2018)

14. EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment. Issue 4 (26th December 2022)

15. Heat shock protein 90 inhibitor NVP‐AUY922 exerts potent activity against adult T‐cell leukemia–lymphoma cells. Issue 12 (5th November 2014)

16. HTLV‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma. (22nd March 2022)

17. Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia. Issue 1 (2nd January 2017)

19. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. Issue 3 (March 2015)

20. Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study. Issue 3 (March 2016)